PDA

View Full Version : Medical Articles and Abstracts


Pages : 1 2 [3] 4 5

  1. Clinical Pharmacokinetics of Lyophilized Recombinant Human Erythropoietin-[Alpha] Fol
  2. Understanding and managing anemia in critically Ill patients
  3. Erythropoietin Study Defends Use in Cancer Anemia
  4. High Person-to-Person Transmission of Bird Flu Reported
  5. Netherlands Finds Case of Variant Cruetzfeldt-Jakob Disease
  6. Recombinant factor VIIa enhances platelet adhesion and activation under flow conditio
  7. Perioperative blood transfusions and delayed wound healing after hip replacement surg
  8. The Anemia of Primary Autonomic Failure and its Reversal with Recombinant Erythropoie
  9. The role of recombinant human erythropoietin alpha in the treatment of chronic anemia
  10. WBC-containing allogeneic blood transfusion and mortality:
  11. Uses and sources of data on long-term survival after blood transfusion.
  12. Long-term survival after blood transfusion: a population based study in the North UK
  13. Influence of transfusions on perioperative and long-term outcome in patients colorect
  14. Use of erythropoietin for bloodless surgery in a Jehovah's witness infant.
  15. Preoperative recombinant human erythropoietin in anemic surgical patients
  16. Hydroxyurea in thalassemia intermedia-a promising therapy
  17. Blood-Conservation Techniques in Craniofacial Surgery
  18. Intraoperative cell salvage during radical prostatectomy is not associated with great
  19. [Permissive anemia]
  20. Microvascular pressure and functional capillary density in extreme hemodilution with
  21. Anemia impact and management: focus on patient needs and the use of erythropoietic ag
  22. Role of iron in anaemic critically ill patients: it's time to investigate!
  23. Orthopaedic-induced anemia: the fallacy of autologous donation programs.
  24. Influence of body core temperature on blood loss and transfusion requirements during
  25. Use of rituximab to treat refractory Diamond-Blackfan anemia
  26. Evaluation of the Hemobag: a novel ultrafiltration system for circuit salvage.
  27. Preoperative iron supplementation and intraoperative transfusion during colorectal ca
  28. Correction of iron-deficient erythropoiesis in the treatment of anemia of chronic dis
  29. Reducing allogeneic transfusion in cardiac surgery: a randomized double-blind placebo
  30. Ethics/Legal - Spondyloptotic fracture of the cervical spine in a pregnant, anemic JW
  31. Ethics & Legal - Treatment without consent: a medicolegal precedent
  32. Ethics & Legal The Jehovah's Witness orthopaedic trauma patient: an ethical challenge
  33. Ethics and Legal - In re Estate of Dorone
  34. Ethics and Legal - Davis v. United States
  35. Successful surgical treatment of a ruptured abdominal aortic aneurysm without homolog
  36. Acute isovolaemic haemodilution in two Jehovah's Witnesses presenting for major intra
  37. Treatment of anaemia in the polytrauma Jehovah's Witness
  38. The risk of death for Jehovah's Witnesses after major trauma
  39. Beneficial effect of acute normovolemic hemodilution in cardiovascular surgery
  40. To Do or Not to Do Living Donor Hepatectomy in Jehovah's Witnesses: Single Institutio
  41. Development and validation of a mathematical algorithm for quantifying preoperative b
  42. Blood sparing in craniosynostosis surgery
  43. Acute normovolemic hemodilution: physiology, limitations, and clinical use.
  44. Predictors of transfusion requirements for cardiac surgical procedures at a blood con
  45. Anaesthesia management of major hepatic resections without application of allogeneic
  46. Effects of standardized acute normovolemic hemodilution on intraoperative allogeneic
  47. Acute normovolemic hemodilution
  48. Reading List
  49. Abstract Links/List - Other
  50. Abstract Links/List - Vascular surgery
  51. Abstract Links/List - Urologic surgery
  52. Abstract Links/List - Trauma
  53. Abstracts Links/List - Transplants
  54. Abstracts Links/List - Transfusion strategies
  55. Abstract Links/List - Transfusion issues
  56. Abstracts Links/List - Thrombopoietin
  57. Abstract Links/List - Thoracic surgery
  58. Abstract Links/List - Thermal injury
  59. Abstract Links/List - Preterm infant
  60. Abstract Links/List - Orthopedic surgery
  61. Abstract Links/List - Oncology
  62. Abstract Links/List - Normovolemic hemodilution
  63. Abstract Links/List - Neurosurgery
  64. Abstract Links/List - Laparoscopic surgery
  65. Abstract Links/List - Interventional radiology
  66. Abtracts Links/List - Hyperbaric oxygen therapy
  67. Abstracts Links/List - Hypotensive anesthesia
  68. Leukocyte filtration and miniature perfusion during arrested heart CABG on a Jehovah'
  69. Abstract Links/List - Hypothermia
  70. Abstract Links/List - Hematological diseases
  71. Abstract Links/List - Head and neck surgery
  72. Abstract Links/List - Gynecologic surgery
  73. Abstract Links/List - General Surgery
  74. Abstract Links/List - Erythropoietin
  75. Abstract Links/List - Coagulants
  76. Abstract Links/List - Cardiac surgery
  77. Abstract Links/List - Blood substitutes
  78. Abstracts Links/List - Blood salvage
  79. Abstract Links/List - Anesthesiology
  80. Influence of body core temperature on blood loss and transfusion requirements during
  81. Transfusion-related acute lung injury following allogeneic bone marrow transplantatio
  82. Allogenic blood transfusion in the first 24 hours after trauma is associated with inc
  83. Recombinant Human Coagulation Factor VIIa in Jehovah's Witness Patients Liver Transpl
  84. Laparoscopic nephrectomy for autosomal dominant polycystic kidney disease.
  85. Acute lung injury after blood transfusion in mechanically ventilated patients
  86. Erythropoietin is an effective clinical modality for reducing RBC transfusion in join
  87. Use of hemoglobin raffimer for postoperative life-threatening anemia in a Jehovah's W
  88. To Do or Not to Do Living Donor Hepatectomy in Jehovah's Witnesses: Single Institutio
  89. Orthopedic Blood Avoidance
  90. Efficacy and safety of recombinant factor VIIa for treatment of severe bleeding: A sy
  91. Perioperative blood transfusion and survival following curative hepatic resection for
  92. The Search for a Blood Substitute
  93. Endovascular Stent Grafting for Thoracic Aneurysms in Jehovah's Witnesses: Report of
  94. Undiagnosed anemia common with chronic illness
  95. Cell Salvage in Obstetrics - Is It Time?
  96. Erythropoietin and Iron
  97. Anemia in Patients With Cancer or Undergoing Cancer Therapy: Impact and Current Treat
  98. Anemia and Blood Transfusion in the Critically Ill Patient
  99. The Limits of Bloodless Surgery
  100. Tolerance of Acute Anemia: The Anesthesiology Perspective
  101. Relationship of blood transfusion and clinical outcomes in patients with acute corona
  102. Toward an understanding of transfusion-related acute lung injury: statement of a cons
  103. Joint ASH and AABB educational session
  104. The risks of blood transfusions and the shortage of supply leads to the quest for blo
  105. Extreme Intraoperative Blood Loss and Hemodilution in a Jehovah's Witness: New Aspect
  106. The use of recombinant factor VIIa for bleeding in paediatric practice.
  107. The use of activated recombinant coagulation factor VII during haemarthroses and syno
  108. Cost implications of post-surgical morbidity following blood transfusion in cancer pa
  109. [Endoscopic extraperitoneal radical prostatectomy. Results after 300 procedures]
  110. Maternal blood loss by expansion of uterine incision at caesarean section--a comparis
  111. Impact of surgical era on outcomes of patients undergoing elective atherosclerotic as
  112. Surgical management of severe obstetric hemorrhage: experience with an obstetric hemo
  113. [Supplemental survey in 2003 concerning life-threatening hemorrhagic events in the op
  114. Treatment of uncontrolled hemorrhagic shock after liver trauma: fatal effects of flui
  115. Life-threatening postoperative blood loss in a Jehovah's Witness, treated with high-d
  116. How to approach major surgery where patients refuse blood transfusion
  117. Erythropoietin use in a pregnant Jehovah's witness with anemia and beta-thalassemia:
  118. Rapid, high-dose intravenous iron sucrose therapy in 2 Jehovah's Witness patients wit
  119. Patients with pertrochanteric hip fracture may benefit from preoperative intravenous
  120. Bench-to-bedside review: iron metabolism in critically ill patients.
  121. The theory and practice of bloodless surgery
  122. Hyperoxia in extreme hemodilution.
  123. Influence of storage on red blood cell rheological properties.
  124. Comparative Effects of Red Blood Cell Transfusion and Increasing Blood Flow on Tissue
  125. Hematocrit value on intensive care unit entry influences thefrequency of q-wave myoca
  126. Chronic myeloproliferative disorders.
  127. Tandem high-dose therapy (HDT) for multiple myeloma: recombinant human erythropoietin
  128. Bone marrow transplantation.
  129. Quality of red blood cells using the Dideco Electa autotransfusion device
  130. Combination of acute preoperative plateletpheresis, cell salvage, and aprotinin minim
  131. The erythropoietin-receptor pathway modulates survival of cancer cells
  132. Recombinant activated factor VII in patients with cancer and hemorrhagic disseminated
  133. A randomized comparison of every-2-week darbepoetin alfa and weekly epoetin alfa for
  134. Prior red blood cell transfusions in cancer patients increase the risk of subsequent
  135. Anemia in patients on combined androgen block therapy for prostate cancer
  136. Emerging infectious threats to the blood supply
  137. An analysis of 55 patients concerning the significance of ductal and radial margins
  138. application of hyperbaric oxygen in the treatment of severe anemia
  139. activated recombinant factor VII for intractable hemorrhage after cardiovascular surg
  140. Blood Collection and Transfusion in the United States in 1999
  141. Cell Salvage in Obstetrics: The Time Is Now
  142. Recombinant human erythropoietin therapy in low-birthweight preterm infants
  143. Efficacy and cost effectiveness of harmonic scalpel compared with electrocautery
  144. Blood Transfusion in Patients With Acute Coronary Syndrome
  145. Strict red blood cell transfusion guideline reduces the need for transfusions in.....
  146. Recombinant Activated Factor VII Intracerebral Hemorrhage Trial Investigators. Recomb
  147. Preoperative use of enoxaparin increases the risk of postoperative bleeding and re-ex
  148. Blood Transfusion Predicts Mortality in Patients with Blunt Spleen and Liver Injuries
  149. Treatment of Life-Threatening Hemorrhage Following Blunt Trauma: The Role of Recombin
  150. Haemovigilance in a general university hospital: need for a more comprehensive classi
  151. Strategies to optimize the use of erythropoietin and iron therapy in oncology patient
  152. The effect of aprotinin on blood loss in bilateral total knee arthroplasty
  153. Number needed to treat and cost of recombinant human erythropoietin to avoid one tran
  154. The safety and efficacy of "bloodless" cardiac surgery
  155. Blood conservation and the management of perioperative blood transfusions in a patien
  156. Alternatives to blood in the 21st century
  157. Immunologic mechanisms of EPO-associated pure red cell aplasia.
  158. Clinical characteristics of erythropoietin-associated pure red cell aplasia
  159. Safety and efficacy of superselective angioembolization in control of lower gastroint
  160. Phase III clinical trials with darbepoetin: implications for clinicians.
  161. FDA Drug Approval Summary: Azacitidine (5-azacytidine, VidazaTM) for Injectable Suspe
  162. Prognostic factors of surgical resection in middle and distal bile duct cancer: An an
  163. A systematic review of the application of hyperbaric oxygen in the treatment of sever
  164. Early experience with activated recombinant factor VII for intractable hemorrhage aft
  165. Recommended practices for endoscopic minimally invasive surgery
  166. Recommended practices for electrosurgery.(Recommended Practices)
  167. The Robot Is In -- And Ready to Operate
  168. Autologous Stem-Cell Transplantation Can Be Performed Safely Without the Use of Blood
  169. Emerging Infectious Threats to the Blood Supply
  170. Beneficial effect of acute normovolemic hemodilution in cardiovascular surgery
  171. A survey of autologous blood transfusion practices in Germany
  172. Cardiovascular response to acute normovolemic hemodilution in patients with coronary
  173. Two injections of erythropoietin correct moderate anemia in most patients awaiting or
  174. Correction of iron-deficient erythropoiesis in the treatment of anemia of chronic dis
  175. An Approach to Anemia in Critically Ill Patients: Transfusion or Tolerance?
  176. Blood transfusion and pulmonary lipid peroxidation in ventilated premature babies
  177. Relationship of blood transfusion and clinical outcomes in patients with acute corona
  178. Blood transfusion is associated with donor leukocyte microchimerism in trauma patient
  179. Commentary: Blood Transfusion and Clinical Outcomes in Patients With Acute Coronary S
  180. Modified extrapleural ligation of patent ductus arteriosus: a convenient surgical app
  181. Laparoscopic restorative proctocolectomy
  182. Efficacy and cost effectiveness of harmonic scalpel compared with electrocautery in p
  183. Transfusion-free pediatric burn surgery: techniques and strategies
  184. Targeted Oxygen Delivery: A New Alternative to Red Cell Transfusion
  185. Modern concepts of autologous haemotherapy
  186. Effect of peri-operative red blood cell transfusion on 30-day and 1-year mortality fo
  187. Allogeneic transfusion and infection: economic and clinical implications
  188. Association of ABO-mismatched platelet transfusions with morbidity/mortality
  189. Anemia and blood transfusion in critically ill patients
  190. Bacterial contamination of blood components: risks, strategies, and regulation
  191. Blood replacement in elective surgery: results of the Sanguis Study
  192. Forty Years of Clinical Aprotinin Use: A Review of 124 Hypersensitivity Reactions
  193. Modified extrapleural ligation of patent ductus arteriosus: a convenient surgical app
  194. High co-prevalence of genogroup 1 TT virus and human papillomavirus is associated wit
  195. Role of parenteral iron in the management of anaemia in the elderly patient undergoin
  196. Tranexamic Acid Reduces Intraoperative Blood Loss in Pediatric Patients Undergoing Sc
  197. Recommended practices for endoscopic minimally invasive surgery
  198. Medical hemostasis in experimental liver resection with antifibrinolytic therapy
  199. A 44-year-old Jehovah's Witness with life-threatening anemia from uterine bleeding
  200. Transfusion-related acute lung injury
  201. Transfusion-related acute lung injury
  202. Blood transfusion associated fatalities
  203. Intraoperative blood salvage: fluid replacement calculations
  204. The role of recombinant factor VIIa in the treatment of life-threatening haemorrhage
  205. Blood transfusion is an independent predictor of increased mortality
  206. rHuEpo before high-dose therapy allows autologous peripheral stem-cell transp
  207. Recombinant erythropoietin in clinical practice
  208. The Role of Recombinant Human Erythropoietin in the Treatment of Thalassemia
  209. Anemia, allogenic blood transfusion, and immunomodulation in the critically ill
  210. Drug for hemophiliacs may help stroke victims
  211. Antifibrinolytic agents in traumatic haemorrhage
  212. Development and implementation of a bloodless medicine and surgery program.
  213. The Public Health Impact Of Prion Diseases
  214. Objectives of a bloodless surgery program
  215. Blood conservation in total joint arthroplasty: blood as a drug
  216. Prevalence and outcomes of anemia in surgery: a systematic review of the literature
  217. Comparative Effects of Red Blood Cell Transfusion and Increasing Blood Flow on Tissue
  218. Leukocyte filtration and miniature perfusion arrested heart CABG Jehovah's Witness
  219. Long-term Use of Hydroxyurea for Sickle Cell Anemia
  220. Autologous blood procurement--acute normovolemic hemodilution vs. PAD
  221. Ordering blood for the wrong patient--getting inside the minds of ordering physicians
  222. Determinants of hospital mortality of adult recipients of right lobe live donor liver
  223. Risks of blood transfusion
  224. Emerging risks and outcomes of blood transfusion in surgery
  225. Blood transfusion risks in the intensive care unit
  226. Surgery and transfusion in Jehovah's witness patient. Medical legal review
  227. Live donor liver transplantation without blood products: strategies developed for JWs
  228. Jehovah's Witnesses requiring complex urgent cardiothoracic surgery
  229. Cell salvage in obstetrics: leucocyte depletion filtration to remove amniotic fluid
  230. Two cases of severe postpartum anaemia in Jehovah's witnesses
  231. Responses by pregnant Jehovah's Witnesses on health care proxies
  232. Pre-myomectomy uterine artery embolisation minimises operative blood loss
  233. Fewer Blood Transfusions May be Linked to Reduced Stroke Risk
  234. Great Website for Cardiac Surgeons
  235. Evaluating and Treating Active Patients for Anemia
  236. Anemia is an independent predictor of mortality after percutaneous coronary
  237. Jehovah's witnesses requiring complex urgent cardiothoracic surgery
  238. Oxygen Transport and Delivery
  239. The Transfusion Trigger - Indications for Red Cell Therapy
  240. The Physiology of Oxygen Delivery
  241. New Trends in Oxygen Delivery, Consumption and Debt Assessment: Global and Regional I
  242. New Trends in Oxygen Delivery, Consumption and Debt Assessment: Global and Regional
  243. Allogeneic Transfusion vs Alternatives - Costs
  244. Does a perception of increased blood safety mean increased blood transfusion? An asse
  245. Does a perception of increased blood safety mean increased blood transfusion? An asse
  246. Epoetin alfa treatment for acute anaemia during interferon plus ribavirin combination
  247. Autologous transfusion techniques: a systematic review of their efficacy
  248. Window-period human immunodeficiency virus transmission to two recipients by an adole
  249. Glycoprotein IIb/IIIa inhibition enhances platelet nitric oxide release
  250. Low-dose oral vitamin K is safe and effective for outpatient management of INR>10